Quest Diagnostics Stock: Is Wall Street Bullish or Bearish?

Valued at $17.1 billion by market cap, Quest Diagnostics Incorporated (DGX) is a leader in diagnostic testing services. Based in Secaucus, New Jersey, the company specializes in providing a broad range of diagnostic information services, including clinical testing and risk assessment solutions, both in the U.S. and internationally.

Shares of this medical laboratory operator have underperformed the broader market over the past 52 weeks. DGX has gained 16.3% over this time frame, while the broader S&P 500 Index ($SPX) has soared 27.5%. In 2024, shares of Quest Diagnostics are up 11.6%, compared to SPX’s 17.8% gain on a YTD basis.